Phase 2 Clinical Trial

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials

Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue

Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial

Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue

Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial

Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study

Cellectar Receives $2M NIH Grant For Rare Lymphoma Study

Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study

Cellectar Receives $2M NIH Grant For Rare Lymphoma Study

Celcuity Teams Up With MD Anderson, Novartis, Puma Biotech To Study New Drug Regimen In Breast Cancer

Annovis Bio Stock Is Trading Higher After Parkinson's Med Shows Improvement In Speed, Coordination

Phase 2 Clinical Trial Recent News

Adamis Pharma's Tempol Decreases COVID-19 Related Lung Inflammation In Animal Studies

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) has

Clene's Lead Candidate Shows Improvement In Functional Scores In Multiple Sclerosis Studies

Ayala Pharmaceuticals Raises $25M Via Equity To Fund AL102 Development In Connective Tissue Tumors

Verona Pharma's pMDI Ensifentrine Shows Improved Lung Function In Mid-Stage COPD Study

Synthetic Biologics Surges 25% Amid Positive Phase 2 Data